Chemistry Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,539
Closed -$237K 142
2022
Q4
$237K Buy
2,539
+49
+2% +$4.73K 0.09% 123
2022
Q3
$237K Sell
2,490
-210
-8% -$20.8K 0.09% 121
2022
Q2
$250K Hold
2,700
0.1% 124
2022
Q1
$273K Sell
2,700
-1,228
-31% -$129K 0.09% 118
2021
Q4
$405K Buy
+3,928
New +$363K 0.34% 58

Other funds holding CVS

Chemistry Wealth Management's CVS Position: Q1 2023 in Review

Chemistry Wealth Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,539 shares — an estimated $237K sold.

Chemistry Wealth Management first reported a position in CVS in Q4 2021 and held it in 5 quarters. The position peaked at $405K in Q4 2021. 2,268 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Chemistry Wealth Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Chemistry Wealth Management sold 2,539 CVS Health shares in Q1 2023, an estimated $237K.
  • Chemistry Wealth Management first reported a position in CVS Health in Q4 2021 and held it in 5 quarters.
  • Chemistry Wealth Management's CVS Health position peaked at $405K in Q4 2021.
  • 2,268 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Chemistry Wealth Management's 13F filing for Q1 2023, filed 10 Apr 2023.